Current role
Fouzia Laghrissi-Thode, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Fouzia Laghrissi-Thode, M.D.
Minerva Neurosciences, Inc. reported in an 8-K filed May 5, 2023 that Fouzia Laghrissi-Thode, M.D. was appointed Chair of the Compensation Committee, effective May 3, 2023.
“the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed (i) Fouzia Laghrissi-Thode, M.D., who currently serves as a member of the Compensation Committee, as the new Chair of the Compensation Committee”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Minerva Neurosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Remy Luthringer CEO
- Frederick Ahlholm CFO, Chief Accounting Officer
- Joseph Reilly COO
- James O'Connor General Counsel
- James O’Connor General Counsel
- Anthony Aliquo Chief Accounting Officer
- Fouzia Laghrissi-Thode Board Member
- Inderjit Kaul Board Member
- Inderjit Kaul, M.D., MPH Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.